Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$10.73 -0.34 (-3.07%)
At close: Oct 22, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) FCF Margin (2018 - 2026)

Updated

Arcturus Therapeutics Holdings (ARCT) recorded FCF Margin of -672.86% in Q2 2026, down 652.53 percentage points from -20.33% a year earlier but up 270.42 percentage points from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) FCF Margin (2018 - 2026) Analysis & Trends

On a TTM basis, Arcturus Therapeutics Holdings' FCF Margin came in at -247.97% as of Jun 30, 2026, down 194.62 percentage points year-over-year; for FY2025, it came in at -90.82%, down 51.17 percentage points from FY2024.

  • Annual FCF Margin has declined for three straight years, though with a five-year change of +376.77 percentage points (FY2020 to FY2025).
  • Across earlier years, FCF Margin came in at -39.65% in FY2024 (-27.06 pp), -12.59% in FY2023 (-24.37 pp), 11.78% in FY2022 (+1132.01 pp) and -1120.23% in FY2021 (-652.64 pp).
  • Quarterly FCF Margin has ranged from -975.40% in Q1 2022 to 479.64% in Q2 2023 over the past five years.
  • On a year-over-year basis, FCF Margin has declined for four consecutive quarters, with an average year-over-year change of -223.28 percentage points over the last eight quarters.
  • Peak year-over-year performance for FCF Margin in the last five years was a gain of 1532.01 percentage points in Q2 2022, against a drop of 823.22 percentage points in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -943.28% (Q1 2026), -224.28% (Q4 2025) and -101.06% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 25.03%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 18.33%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 26.96%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 38.60%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 6.55%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 34.70%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 44.00%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 2.01%
10 Arcturus Therapeutics Holdings 305.69 Mn -508.44 Mn - -672.86%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -672.86%
Mar 31, 2026 -943.28%
Dec 31, 2025 -224.28%
Sep 30, 2025 -101.06%
Jun 30, 2025 -20.33%
Mar 31, 2025 -120.06%
Dec 31, 2024 -1.25%
Sep 30, 2024 -57.22%
Jun 30, 2024 -61.11%
Mar 31, 2024 -15.25%
Dec 31, 2023 -4.87%
Sep 30, 2023 -73.96%
Jun 30, 2023 479.64%
Mar 31, 2023 -45.54%
Dec 31, 2022 97.60%
Sep 30, 2022 -333.55%
Jun 30, 2022 -134.51%
Mar 31, 2022 -975.40%
Dec 31, 2021 -752.76%
Sep 30, 2021 -755.81%
API Access

Arcturus Therapeutics Holdings FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=ARCT&period=max&api_key=YOUR_API_KEY